Job Search

Find Your Place Here

map

We hire exceptional people who share with us a passion for making a difference in the world. If you are ready to explore the opportunities awaiting you at Daiichi Sankyo, Inc., start your search today.

select
select
select
select

Candidates with Disabilities Who Require Assistance

Daiichi Sankyo, Inc. provides reasonable accommodation in job application procedures for qualified individuals with disabilities and disabled veterans. If you have a disability that inhibits your ability to apply for a position through our online application process or you otherwise need accommodation in connection with the recruiting process due to a disability, you may use the alternative methods described below to contact us about your interest in Daiichi Sankyo, Inc. and/or to request an accommodation. By Email: dsirecruiting@dsi.com By Mail: 2 Hilton Court, Parsippany, NJ 07054 Assistance by Phone: 973-944-2271 Please note these methods are intended for use only by those applicants who need to request an accommodation in connection with the recruiting process due to a disability. If you send correspondence to these addresses that is about something other than a request for an accommodation in connection with the recruiting process due to a disability, you will not receive a reply. Thank you for your understanding and cooperation
If you are selected to interview for a position you may also request an accommodation with your Recruiter directly.

Equal Opportunity Employment

Daiichi Sankyo, Inc., is an Equal Opportunity Employer Minorities/Females/Disabled/Protected Veterans. We consider all eligible current and prospective employees for employment opportunities without regard to race, color, citizenship, national origin and ancestry, religion, gender, sexual orientation, genetic information, age, disability, marital status, veteran status and other characteristics in accordance with applicable federal, state and local laws.

Create Candidate Profile Follow Us Onlinkedin

Latest News

Daiichi Sankyo, Inc. Announces Civil Settlement.
01/09/15
U.S. FDA Approves Daiichi Sankyo’s Once-Daily SAVAYSA™ (edoxaban) Tablets ...
01/08/15
Global Survey of Cardiologists Highlights Complexity of Managing Non-Valvu...
01/31/14
RSS